HIV News and Research

RSS

Likelihood of SARS-CoV-2 transmission may depend on blood type of spreader and recipient

A modeling study by Dr. Peter Ellis from the University of Kent indicates that ABO incompatibility between infected patients and susceptible individuals may actually decrease the transmissibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by 60% or more. His detailed investigation of such "ABO-interference" can be found on the medRxiv preprint server.

15 Jul 2020

Common FDA-approved drug may be a powerful tool in fighting COVID-19

A common drug, already approved by the Food and Drug Administration, may also be a powerful tool in fighting COVID-19, according to research published this week in Antiviral Research.

15 Jul 2020

International research collaboration to investigate the role of immune system in health

An international research collaboration to pioneer the field of immuno-cardiology and investigate ways to harness the power of the immune system to improve recovery from heart attacks will be led at the Perelman School of Medicine at the University of Pennsylvania by Jonathan Epstein, MD, executive vice dean, chief scientific officer and the William Wikoff Smith Professor of Cardiovascular Research.

13 Jul 2020

EKF introduces novel molecular transport media for dual COVID-19 and influenza sampling

EKF Diagnostics the global in vitro diagnostics company, announces that it has added a novel viral transport media for the safe sample handling and testing of multiple infectious diseases from a single swab to its product range.

From EKF Diagnostics 13 Jul 2020

New guidance published for research on HIV, co-infections in pregnancy

Pregnant women are among those most in need of safe and effective preventives and treatments for HIV and co-infections. Yet because they are commonly excluded from research, they are among the least likely to have robust, timely evidence to inform decisions around the use of medications.

12 Jul 2020

Concentration of lopinavir and hydroxychloroquine not sufficient to fight novel coronavirus

Lopinavir is a drug against HIV, hydroxychloroquine is used to treat malaria and rheumatism. Until recently, both drugs were regarded as potential agents in the fight against the coronavirus SARS-CoV-2.

11 Jul 2020

Establishment of global surveillance network can warn about next pandemic

The virus that causes COVID-19 probably originated in wild bats that live in caves around Wuhan, China, and may have been passed to a second animal species before infecting people, according to the World Health Organization.

10 Jul 2020

Pasteurization of breast milk inactivates novel coronavirus

Pasteurizing breast milk using a common technique inactivates severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) making it safe for use, according to new research in CMAJ.

9 Jul 2020

New study identifies challenges and opportunities to promote nurse- and midwife-led HIV services

"Nurse-initiated and managed antiretroviral therapy" (NIMART) is an innovative approach to making effective medications more accessible to people living with HIV (PLWH) in low-resource countries.

9 Jul 2020

HCV testing and treatment at federally qualified health centers can be cost-fffective

New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective.

8 Jul 2020

NIH establishes a unified clinical trial network for testing COVID-19 vaccines

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has established a new clinical trials network that aims to enroll thousands of volunteers in large-scale clinical trials testing a variety of investigational vaccines and monoclonal antibodies intended to protect people from COVID-19.

8 Jul 2020

Fred Hutch joins new clinical trials network to fight COVID-19

Fred Hutchinson Cancer Research Center has been named the coordinating center for vaccine clinical trials of the COVID-19 Prevention Network.

8 Jul 2020

Characterizing Polymorphs and Amorphous Form

Dr. Matteo Daldosso and Dr. Sebastian Wegner discuss novel solutions for the characterization of polymorphs and amorphous form APIs.

From Bruker BioSpin - NMR, EPR and Imaging 8 Jul 2020

NIH study: Long-acting form of HIV prevention drug more effective than daily oral pill

A pre-exposure prophylaxis (PrEP) regimen containing an investigational long-acting form of the HIV drug cabotegravir injected once every 8 weeks was more effective than daily oral Truvada at preventing HIV acquisition among cisgender men who have sex with men and transgender women who have sex with men in a clinical trial sponsored by the National Institutes of Health.

7 Jul 2020

Cerebrospinal fluid autoantibodies target the brain in some COVID-19 patients

A study conducted by German researchers has shown that the neurological symptoms observed in some patients with coronavirus disease 2019 (COVID-19) may be caused by autoantibodies targeting the brain.

7 Jul 2020

SARS-CoV-2 spike protein hidden as pH changes

Now, a new study published on the preprint server bioRxiv in July 2020 reports the role of pH in helping the virus escape neutralization by antibodies, by inducing a key conformational switch.

7 Jul 2020

2021 health plans granted leeway to limit consumers’ benefit from drug coupons

Without medication to manage her plaque psoriasis, Jennifer Brown's face, scalp, trunk and neck periodically become covered in painful red, flaky patches so dry they crack and bleed.

6 Jul 2020

Thermo Scientific MAS Omni Infectious Controls launched to assess the performance of serological assays

Thermo Fisher Scientific, the world leader in serving science, today announced the availability of the Thermo Scientific MAS Omni Infectious Disease quality control sets for monitoring serological assays for analytes such as HIV 1&2, Hepatitis B & C virus, Syphilis and HTLV I/II.

From Thermo Fisher Scientific Inc. 3 Jul 2020

New platform prioritizes synergistic drug combinations against SARS-CoV-2

Researchers in the U.S. have used a new web-based platform to help identify synergistic and antagonistic drug combinations and their underlying mechanisms of action in the context of coronavirus disease 2019 (COVID-19).

2 Jul 2020

Incarceration and police discrimination may worsen health of Black sexual minority men

Incarceration and police discrimination may contribute to HIV, depression and anxiety among Black gay, bisexual and other sexual minority men, according to a Rutgers led study.

2 Jul 2020

HIV News and Research

Likelihood of SARS-CoV-2 transmission may depend on blood type of spreader and recipient

Common FDA-approved drug may be a powerful tool in fighting COVID-19

International research collaboration to investigate the role of immune system in health

EKF introduces novel molecular transport media for dual COVID-19 and influenza sampling

New guidance published for research on HIV, co-infections in pregnancy

Concentration of lopinavir and hydroxychloroquine not sufficient to fight novel coronavirus

Establishment of global surveillance network can warn about next pandemic

Pasteurization of breast milk inactivates novel coronavirus

New study identifies challenges and opportunities to promote nurse- and midwife-led HIV services

HCV testing and treatment at federally qualified health centers can be cost-fffective

NIH establishes a unified clinical trial network for testing COVID-19 vaccines

Fred Hutch joins new clinical trials network to fight COVID-19

Characterizing Polymorphs and Amorphous Form

NIH study: Long-acting form of HIV prevention drug more effective than daily oral pill

Cerebrospinal fluid autoantibodies target the brain in some COVID-19 patients

SARS-CoV-2 spike protein hidden as pH changes

2021 health plans granted leeway to limit consumers’ benefit from drug coupons

Thermo Scientific MAS Omni Infectious Controls launched to assess the performance of serological assays

New platform prioritizes synergistic drug combinations against SARS-CoV-2

Incarceration and police discrimination may worsen health of Black sexual minority men

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News